FDA Greenlights Record Number of Medical Devices

February 18, 2021 by Daniel Mollenkamp
FDA Greenlights Record Number of Medical Devices

WASHINGTON – In a public health milestone, the Food and Drug Administration announced on Tuesday that it approved a record setting amount of novel medical devices in 2020. 

In 2020, the FDA’s Center for Devices and Radiological Health gave the green light to 132 new devices, which the agency described as “capping off” ten years of growth. 

In 2010, by comparison, the agency had only approved 29 devices, and in 2019, they had only approved 71. 

These new figures broke the previous record from 2017, which had been a 40-year record for the institution, showing a consistent increase in activity that has made the FDA a force in the background of American life. 

Despite the framing of the FDA’s written comment, which proclaimed that the agency has encouraged new levels of innovation “despite” the coronavirus, some of the devices would seem to be deeply connected to the virus. 

The figures included devices permitted under the “Emergency Use Authorization,” which in emergencies allows devices that might otherwise be kept from the market, as well as new uses which might be banned for devices already on the market. 

Secretary of Health and Human Services Alex Azar declared a public health emergency over coronavirus in January 2020.   

The agency has since issued numerous emergency authorizations for personal protective equipment. They have also relaxed regulations surrounding equipment such as ventilators, along with similar attempts to streamline the path to market during the public health crisis such as embracing digital health technologies. 

In fact, the FDA has had to take a more relaxed approach to regulations in general since the coronavirus, not merely on medical device approval. Observers have warned that this situation will need to be revisited after the coronavirus crisis is over because while faster approval processes may offer expediency, it might run the risk of lessening patient safety. 

For now, the agency’s attention is more centered on coronavirus than on policy tradeoffs.

“In 2021, work related to COVID-19 will remain our top priority,” CDRH Director Jeff Shuren said in a written statement.

“Although it is impossible to predict with certainty what the future will bring and whether the innovation pipeline in the U.S. will remain strong, CDRH will continue to adapt and shift resources to best protect and promote the public health.”

A+
a-
  • FDA
  • medical devices
  • In The News

    Health

    Voting

    November 30, 2023
    by Tom Ramstack
    Supreme Court Leans Toward Reducing Enforcement Authority of Federal Agencies

    WASHINGTON — The Supreme Court seemed ready Wednesday to cut back on the authority of federal agencies to enforce their... Read More

    WASHINGTON — The Supreme Court seemed ready Wednesday to cut back on the authority of federal agencies to enforce their regulations through fines or seizures of property. Questions from the conservative majority of justices during a hearing focused on whether the agencies were committing unconstitutional procedural... Read More

    November 30, 2023
    by Dan McCue
    Chaos Reigns as Democrats Vote to Subpoena Crow, Leo in SCOTUS Probe

    WASHINGTON — A Senate Judiciary Committee hearing on Thursday became the latest venue for Capitol Hill dysfunction as Democrats on... Read More

    WASHINGTON — A Senate Judiciary Committee hearing on Thursday became the latest venue for Capitol Hill dysfunction as Democrats on the panel approved issuing subpoenas to billionaire Harlan Crow and influential conservative Leonard Leo as part of an ongoing investigation into alleged ethical lapses by Supreme... Read More

    November 30, 2023
    by Dan McCue
    ‘Localizing’ Biden Platform Seen as Key to Democratic Victories in 2024

    WASHINGTON — Democrats hoping to draw lessons from this year’s off-years to apply in 2024 would do well to try... Read More

    WASHINGTON — Democrats hoping to draw lessons from this year’s off-years to apply in 2024 would do well to try to localize the president’s national platform while also continuing to embrace the abortion issue, which still appears to be working for the party. That was the... Read More

    Four Ideas Worth Stealing in 2024

    At this moment of chaos at the federal level, state and local leaders continue to step up to the plate... Read More

    At this moment of chaos at the federal level, state and local leaders continue to step up to the plate to develop and implement bold, effective policy ideas. Whether it’s programs utilizing historic investments to boost economic development, supporting our democratic institutions or making it easier... Read More

    November 30, 2023
    by Dan McCue
    New York Appellate Court Reinstates Trump Gag Orders

    NEW YORK — A New York appeals court panel on Thursday reinstated a pair of gag orders issued in Donald... Read More

    NEW YORK — A New York appeals court panel on Thursday reinstated a pair of gag orders issued in Donald Trump’s civil fraud trial that barred the former president from speaking publicly about the judge’s court staff. The two-page decision by the New York State Supreme... Read More

    Anthony Fauci to Testify Before Congress on COVID Origins and US Pandemic Response

    WASHINGTON (AP) — Anthony Fauci, former chief White House medical adviser, is expected to testify before Congress early next year... Read More

    WASHINGTON (AP) — Anthony Fauci, former chief White House medical adviser, is expected to testify before Congress early next year as part of Republicans' yearslong investigation into the origins of COVID-19 and the U.S. response to the disease. Fauci, who served as the nation's top infectious... Read More

    News From The Well
    scroll top